Development of a Blood Based Protein Signature to Stratify Patients for Prostate Cancer Treatment. From Discovery to Clinical DiagnosticsTuesday, 27 January 2015 at 16:00 Add to Calendar ▼2015-01-27 16:00:002015-01-27 17:00:00Europe/LondonDevelopment of a Blood Based Protein Signature to Stratify Patients for Prostate Cancer Treatment. From Discovery to Clinical DiagnosticsDiagnostics and Biomarkers - Online Event in OnlineOnlineSELECTBIOenquiries@selectbiosciences.com Having established an end-user driven clinical need we are implementing a strategy to progress protein biomarkers from individual candidates into protein signatures of clinical diagnostic utility. This strategy takes advantage of a consortium based approach for the identification of candidates and acquisition of patient samples for clinical evaluation of the protein signature in a manner that supports commercialisation for delivery. |